Nick D’Ambrosio is a 51-year-old Italian Canadian from Montréal, Québec living with sight loss due to an inherited retinal disease called retinitis pigmentosa (RP). Following an early diagnosis, Nick found it difficult…

Starting in 2023, a new clinical trial called NAC Attack will be launched to test an oral medication, N-acetylcysteine (NAC), as a potential therapy for patients with retinitis pigmentosa (RP). NAC Attack…

Dr. Sachdev Sidhu (University of Toronto) is a biomedical engineer with extensive experience in drug development. Dr. Sidhu established the Toronto Recombinant Antibody Centre (TRAC) which houses a state-of-the-art platform to generate…

Teamwork really does make the dream work! We are excited to share news of a Fighting Blindness Canada (FBC) funded discovery recently published in the journal Science Advances achieved through a collaboration…

Fighting Blindness Canada is pleased to hear the announcement that Canadians are one step closer to accessing Luxturna® (generic name: voretigene neparvovec)i, a sight-saving gene therapy. The pan-Canadian Pharmaceutical Alliance has concluded…

Comic Vision is Fighting Blindness Canada’s (FBC) signature comedy show in support of vision research and has been bringing people together since 1999, spreading hope, vision loss awareness, and education by using…